---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286569600.md"
description: "ARS Pharmaceuticals shares are trading lower after the company reported mixed Q1 financial results."
datetime: "2026-05-15T12:48:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286569600.md)
  - [en](https://longbridge.com/en/news/286569600.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286569600.md)
---

# 

ARS Pharmaceuticals shares are trading lower after the company reported mixed Q1 financial results.

### Related Stocks

- [SPRY.US](https://longbridge.com/en/quote/SPRY.US.md)

## Related News & Research

- [ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update | SPRY Stock News](https://longbridge.com/en/news/286543133.md)
- [ARS Pharmaceuticals Highlights Strong Neffy Growth and Global Expansion](https://longbridge.com/en/news/286552367.md)
- [ARS Pharmaceuticals Q1 revenue beats estimates on neffy sales growth](https://longbridge.com/en/news/286545099.md)
- [Key facts: ARS neffy approved US/Canada/EU; rev $22.7M, loss $60.6M](https://longbridge.com/en/news/286637608.md)
- [ARS Pharmaceuticals Q4 revenue beats expectations on strong neffy sales](https://longbridge.com/en/news/278370109.md)